Camurati-Engelmann Syndrome: Clinical Trials

58 trials for Camurati-Engelmann Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

27 completed, 9 terminated, 9 unknown, 7 recruiting. 18 Phase 2, 14 Phase 1, 11 Not applicable, 5 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 218Completed 8, Terminated 6, Recruiting 2, Active not recruiting 1, Withdrawn 1
Phase 114Completed 6, Terminated 4, Active not recruiting 2, Recruiting 1, Withdrawn 1
Not applicable11Completed 7, Active not recruiting 2, Recruiting 1, Unknown 1
Phase 35Unknown 3, Recruiting 1, Terminated 1
Phase 42Unknown 2
Early Phase 11Unknown 1

Follow Camurati-Engelmann Syndrome: new trials by email Literature Review of Camurati-Engelmann Syndrome trials Research Report on Camurati-Engelmann Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC
Ficerafusp alfa, Pembrolizumab (KEYTRUDA®) - Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 2RecruitingBicara Therapeutics1602026-09-012026-10-13
The Role of Transforming Growth Factor- Beta (TGF- β) Expression in Renal Biopsy of Lupus Nephritis Patients
renal biopsy - Lupus Nephritis (LN)
Not applicableActive not recruitingAin Shams University302026-05-312026-09-16
Effects of Non-Surgical Periodontal Treatment on Inflammatory and Bone Markers in Periodontitis Patients
Scaling and Root Planing (SRP) - Periodontitis (Stage 3)
Not applicableActive not recruitingSaglik Bilimleri Universitesi562026-03-152026-04-27
Salivary Biomarkers in Periodontal Disease Progression
Saliva Sampling - Periodontal Disease, Gingivitis and Periodontal Diseases
RecruitingSuleyman Demirel University2402025-07-102026-06-22
Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes
Pancreatogenic Diabetes Mellitus, Type 2 Diabetes Mellitus (T2DM)
RecruitingWest Kazakhstan Marat Ospanov Medical University3102025-07-072026-04-06
Intravitreal Triamcinolone and Biomarkers in Rhegmatogenous Retinal Detachment
Standard Vitrectomy, Triamcinolone acetonide (TA) - Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
Not applicableCompletedAnggun Rama Yudantha602025-05-062026-08-19
An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
HCB301 - Advanced Solid Tumor, Refractory Hodgkin Lymphoma
Phase 1RecruitingFBD Biologics Limited502025-04-022026-04-13
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Ficerafusp alfa, Pembrolizumab (KEYTRUDA®), Placebo - Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 2 / Phase 3RecruitingBicara Therapeutics6502025-01-282026-10-02
Evaluation of Albumin Platelet-Rich Fibrin Following SRP in Patients With Periodontitis
Albumin platelet-rich fibrin, Sterile saline (0.9%) - Periodontitis, Periodontitis (Stage 3)
Not applicableCompletedSaglik Bilimleri Universitesi232024-11-202026-02-17
Loss of Y Chromosome in Aortic Stenosis
Blood analysis for loss-of-Y chromosome - Aortic Stenosis
UnknownUniversity of Virginia2002024-08-152024-09-19
Metformin Repurposing in Oral Submucous Fibrosis: Unveiling In Vitro Signaling Pathways, Progressing to Clinical Trial
Metformin Hydrochloride, betamethasone dipropionate, Pentoxifylline - Oral Submucous Fibrosis
Phase 1 / Phase 2CompletedZiauddin University302024-08-122025-05-02
Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients
Losartan 25 milligram capsule, Placebo - Radiation Induced Fibrosis
Phase 2Active not recruitingShaw Cancer Center432023-08-172026-06-18
Effect of Calcium Silicate Based Root Canal Medicament on Inflammatory Mediators
Calcium Hydroxide, Calcium Silicate - Periapical; Infection
Not applicableCompletedAtaturk University602023-07-072024-03-13
Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis
Pioglitazone 30mg, Empagliflozin 10 MG - Non Alcoholic Steatohepatitis
Phase 3UnknownTanta University562022-11-012022-11-04
Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients Sera
sofosbuvir and daclatasvir - Hepatitis C, Chronic
Early Phase 1UnknownAssiut University402022-10-012022-07-26
Investıgatıon of The Effıciency of Pulsed Electromagnetıc Field Therapy and Stretching Exercises
Exercise, Pulsed Electromagnetic Field Therapy - Muscle Injury, Pulsed Electromagnetic Therapy
Not applicableCompletedSuleyman Demirel University642022-09-052023-08-14
Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct
Colchicine, Percutaneous Coronary Intervention, Optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate. - ST Elevation Myocardial Infarction, Colchicine
Phase 4UnknownRSD dr. Soebandi1482022-06-012023-04-11
Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy
Peripheral immunological assessment on venous blood, Immunological assessment carried out on intracardiac material - Arrhythmogenic Right Ventricular Dysplasia
Not applicableRecruitingUniversity Hospital, Toulouse802022-02-012026-06-01
Assessment of Growth Factors Levels Associated with Wound Healing After Soft Tissue Crown Lengthening
single intervention by Sirolase ® lower power diode laser 970 ± 15 nm (0.5 watts) continuous emission, power =3 watts, fiber 320 μm, single intervention by electrosurgical unit which was kept 38 watts rms ± 5%. The working frequency was adjusted to 1.5 MHz ± 5%. - Gingival Overgrowth
Phase 2CompletedAl-Azhar University802021-10-032025-02-04
Study of TST005 in Patients With Locally Advanced or Metastatic Solid Tumors
TST005 - Locally Advanced or Metastatic Cancers, Metastatic Human Papillomavirus-Related Malignant Neoplasm
Phase 1TerminatedTranscenta Therapeutics (Hangzhou) Co., Ltd.192021-06-112023-10-23

Showing 20 of 58. Sign in to see all of them.

Narrower conditions

Breast Neoplasms (5)  ·  Fibrosis (5)  ·  Neoplasms (5)  ·  Head and Neck Neoplasms (3)  ·  Inflammation (3)  ·  Neoplasm Metastasis (3)  ·  Periodontitis (3)  ·  Biliary Tract Neoplasms (2)  ·  Carcinoma, Hepatocellular (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Carcinoma, Transitional Cell (2)  ·  Cholangiocarcinoma (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Eosinophilic Esophagitis (2)

Broader conditions

Bone Diseases (58)  ·  Bone Diseases, Developmental (58)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (58)  ·  Genetic Diseases, Inborn (58)  ·  Musculoskeletal Diseases (58)  ·  Osteochondrodysplasias (58)  ·  Neoplasms by Site (17)  ·  Neoplasms (16)  ·  Pathological Conditions, Signs and Symptoms (16)  ·  Pathologic Processes (13)  ·  Neoplasms by Histologic Type (12)  ·  Digestive System Diseases (11)  ·  Neoplasms, Glandular and Epithelial (10)  ·  Carcinoma (9)  ·  Cardiovascular Diseases (9)

Interventions

Cisplatin (3)  ·  Losartan (3)  ·  Radiotherapy (3)  ·  bintrafusp alfa protein, human (3)  ·  pembrolizumab (3)  ·  Gemcitabine (2)  ·  Triamcinolone Acetonide (2)  ·  130-nm albumin-bound paclitaxel (1)  ·  Anastrozole (1)  ·  Aspirin (1)  ·  Attachment Sites, Microbiological (1)  ·  Betamethasone Valerate (1)  ·  Bevacizumab (1)  ·  Blood Specimen Collection (1)  ·  Calcium Hydroxide (1)

Sponsors

EMD Serono Research & Development Institute, Inc. (3)  ·  Eli Lilly and Company (3)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3)  ·  Baylor College of Medicine (2)  ·  Bicara Therapeutics (2)  ·  National Cancer Institute (NCI) (2)  ·  Saglik Bilimleri Universitesi (2)  ·  Suleyman Demirel University (2)  ·  Weill Medical College of Cornell University (2)  ·  Ain Shams University (1)  ·  Al-Azhar University (1)  ·  Anggun Rama Yudantha (1)  ·  Assiut University (1)  ·  Ataturk University (1)  ·  Boston Scientific Corporation (1)

Countries

United States (29)  ·  France (7)  ·  Spain (7)  ·  Turkey (Türkiye) (7)  ·  Germany (6)  ·  Italy (6)  ·  Japan (6)  ·  China (5)  ·  Egypt (5)  ·  South Korea (5)  ·  Taiwan (5)  ·  Australia (4)  ·  Poland (4)  ·  United Kingdom (4)  ·  Thailand (3)

Top investigators

Aarti Sharma, MD (1)  ·  Alessandro M Gianni, MD (1)  ·  Andrea B Apolo, M.D. (1)  ·  Andrea Necchi, MD (1)  ·  Andrew M Scott, MBBS (1)  ·  Anggun Rama Yudantha, Sp.M(K) (1)  ·  Byung-Kiu Park, M.D., Ph.D. (1)  ·  Charlie Qi, MD (1)  ·  Dincer Avlan, Profesor, MD (1)  ·  Eloisa Arbustini, MD,FESC,FACC (1)

Results publications

PMID 32461347, PMID 11834520, PMID 12525569, PMID 15579374, PMID 15955304, PMID 16183806, PMID 16601194, PMID 16622779, PMID 17099022, PMID 17188619, PMID 17911499, PMID 19430350, PMID 24062613, PMID 24566706, PMID 24890385, PMID 25301274, PMID 26009202, PMID 28390753, PMID 30411986, PMID 30554141, PMID 31296256, PMID 31472446, PMID 31795071, PMID 33008091, PMID 33193670, PMID 34007848, PMID 34548321, PMID 34769657, PMID 35410255, PMID 36552855, PMID 36999533, PMID 37525914, PMID 38087967, PMID 38875119, PMID 39214047, PMID 40155539, PMID 42155862, PMID 42231297, PMID 8166795

NIH funding

2019 (2), 2016 (1), 2018 (1), P01CA094237 (1)